Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database
Abstract Background Parkinson’s disease is complicated by comorbidity and polypharmacy, but the extent and patterns of these are unclear. We describe comorbidity and polypharmacy in patients with and without Parkinson’s disease across 31 other physical, and seven mental health conditions. Methods We...
Main Authors: | Gary McLean, John V. Hindle, Bruce Guthrie, Stewart W. Mercer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | BMC Neurology |
Online Access: | http://link.springer.com/article/10.1186/s12883-017-0904-4 |
Similar Items
-
Chronic Migraine, Comorbidity, and Socioeconomic Deprivation: Cross-Sectional Analysis of a Large Nationally Representative Primary Care Database
by: Gary McLean, et al.
Published: (2017-01-01) -
Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden
by: Gallacher, Katie I., et al.
Published: (2014) -
The Affiliates with the Scottish School of Primary Care
by: Stewart W. Mercer, et al.
Published: (2017-01-01) -
Differences in the quality of primary medical care for CVD and diabetes across the NHS: evidence from the quality and outcomes framework
by: Sutton Matt, et al.
Published: (2007-05-01) -
Multi-Morbidity in the Older Person: An Examination of Polypharmacy and Socioeconomic Status
by: Martin C. Nwadiugwu, et al.
Published: (2021-01-01)